Literature DB >> 8020813

Viruses and hepatocellular carcinoma.

S Sherlock1.   

Abstract

Entities:  

Mesh：

Year:  1994        PMID： 8020813      PMCID： PMC1374888          DOI： 10.1136/gut.35.6.828

Source DB:  PubMed          Journal:  Gut        ISSN： 0017-5749            Impact factor:   23.059


× No keyword cloud information.
  47 in total

1.  Postresection recurrence of hepatocellular carcinoma treated by arterial embolization: analysis of prognostic factors.

Authors:  K Takayasu; F Wakao; N Moriyama; Y Muramatsu; S Yamazaki; T Kosuge; T Takayama; S Okada; N Okazaki; M Makuuchi
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

Review 2.  Hepatocellular carcinoma.

Authors:  M Colombo
Journal:  J Hepatol       Date:  1992-05       Impact factor: 25.083

Review 3.  Management of hepatocellular carcinoma.

Authors:  K E Hobbs; G M Dusheiko
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

4.  A 5-year study of cryosurgery in the treatment of liver tumors.

Authors:  T S Ravikumar; R Kane; B Cady; R Jenkins; M Clouse; G Steele
Journal:  Arch Surg       Date:  1991-12

5.  Risk factors linked to tumor recurrence of human hepatocellular carcinoma after hepatic resection.

Authors:  S C Jwo; J H Chiu; G Y Chau; C C Loong; W Y Lui
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

6.  Incidence and diagnostic features of macroregenerative nodules vs. small hepatocellular carcinoma in cirrhotic livers.

Authors:  L Ferrell; T Wright; J Lake; J Roberts; N Ascher
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

7.  Hepatitis B X-gene expression in hepatocellular carcinoma.

Authors:  I D Diamantis; C E McGandy; T J Chen; Y F Liaw; F Gudat; L Bianchi
Journal:  J Hepatol       Date:  1992-07       Impact factor: 25.083

8.  Hepatitis B and C viral infections in patients with hepatocellular carcinoma.

Authors:  J Ruiz; B Sangro; J I Cuende; O Beloqui; J I Riezu-Boj; J I Herrero; J Prieto
Journal:  Hepatology       Date:  1992-09       Impact factor: 17.425

9.  Macroregenerative nodules and hepatocellular carcinoma in forty-four sequential adult liver explants with cirrhosis.

Authors:  N D Theise; M Schwartz; C Miller; S N Thung
Journal:  Hepatology       Date:  1992-10       Impact factor: 17.425

10.  Transforming growth factor-alpha in human hepatocellular carcinoma and coexpression with hepatitis B surface antigen in adjacent liver.

Authors:  C C Hsia; C A Axiotis; A M Di Bisceglie; E Tabor
Journal:  Cancer       Date:  1992-09-01       Impact factor: 6.860
View more
  25 in total

1.  De novo hepatocellular carcinoma in a patient with chronic hepatitis C 5 years after sustained virologic response to interferon/ribavirin therapy.

Authors:  Kevin S Sieja; Gregory T Everson
Journal:  Dig Dis Sci       Date:  2006-03       Impact factor: 3.199

2.  Prevention of cancer recurrence after treatment for hepatitis C virus-related hepatocellular carcinoma by interferon therapy.

Authors:  Shoji Kubo
Journal:  Clin J Gastroenterol       Date:  2009-04-08

3.  Previous or occult hepatitis B virus infection in hepatitis C virus-associated hepatocellular carcinoma without hepatic fibrosis.

Authors:  S Kubo; A Tamori; K Ohba; T Shuto; T Yamamoto; H Tanaka; S Nishiguchi; K Wakasa; K Hirohashi; H Kinoshita
Journal:  Dig Dis Sci       Date:  2001-11       Impact factor: 3.199

4.  Inferior Outcomes Associated with the Coexistence of Hepatocellular Carcinoma Recurrence and Hepatic Virus Reinfection After Living Donor Liver Transplantation.

Authors:  Kun-Ming Chan; Tsung-Han Wu; Chih-Hsien Cheng; Chen-Fang Lee; Ting-Jung Wu; Hong-Shiue Chou; Wei-Chen Lee
Journal:  J Gastrointest Surg       Date:  2019-02-04       Impact factor: 3.452

5.  Risk of recurrence in a long-term follow-up after surgery in 417 patients with hepatitis B- or hepatitis C-related hepatocellular carcinoma.

Authors:  Yo Sasaki; Terumasa Yamada; Hideo Tanaka; Hiroaki Ohigashi; Hidetoshi Eguchi; Masahiko Yano; Osamu Ishikawa; Shingi Imaoka
Journal:  Ann Surg       Date:  2006-11       Impact factor: 12.969

Review 6.  Molecular signatures of noncancerous liver tissue can predict the risk for late recurrence of hepatocellular carcinoma.

Authors:  Tohru Utsunomiya; Mitsuo Shimada; Satoru Imura; Yuji Morine; Tetsuya Ikemoto; Masaki Mori
Journal:  J Gastroenterol       Date:  2009-12-08       Impact factor: 7.527

7.  Hepatitis B or C virus serology as a prognostic factor in patients with hepatocellular carcinoma.

Authors:  S A Ahmad; M M Bilimoria; X Wang; F Izzo; P Delrio; P Marra; T P Baker; G A Porter; L M Ellis; J N Vauthey; S Dhamotharan; S A Curley
Journal:  J Gastrointest Surg       Date:  2001 Sep-Oct       Impact factor: 3.452

8.  Successful treatment with lamivudine may correlate with reduction of serum ferritin levels in the patients with chronic hepatitis and liver cirrhosis type B.

Authors:  Shogo Ohkoshi; Akira Yoshimura; Satoshi Yamamoto; Masahiko Yano; So Kurita; Kazuhide Yamazaki; Yo-Hei Aoki; Satoshi Yamagiwa; Hiroto Wakabayashi; Motoya Sugiyama; Tohru Takahashi; Tohru Ishikawa; Yasunobu Matsuda; Takafumi Ichida; Tomoteru Kamimura; Yutaka Aoyagi
Journal:  Hepatol Int       Date:  2008-07-25       Impact factor: 6.047

9.  Sequential changes of serum ferritin levels and their clinical significance in lamivudine-treated patients with chronic viral hepatitis B.

Authors:  Zheng-Wen Liu; Qun-Ying Han; Ni Zhang; Wen Kang
Journal:  World J Gastroenterol       Date:  2004-04-01       Impact factor: 5.742

10.  Surgical results in patients with hepatitis virus-related hepatocellular carcinoma in Taiwan.

Authors:  Miin-Fu Chen; Long-Bin Jeng; Wei-Chen Lee
Journal:  World J Surg       Date:  2002-03-26       Impact factor: 3.352
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.